Free Trial

State of Wyoming Trims Holdings in Maximus, Inc. $MMS

Maximus logo with Business Services background

Key Points

  • The State of Wyoming reduced its holdings in Maximus, Inc. by 68.4% in the first quarter, leaving it with 3,527 shares valued at $241,000.
  • Several hedge funds have increased their positions in Maximus significantly, with Caitong International Asset Management growing its position by 17,533.3% during the same period.
  • Maximus reported a strong earnings performance, with $2.16 earnings per share, surpassing analysts' expectations of $1.39, and set guidance for FY 2025 at 7.350-7.550 EPS.
  • Five stocks to consider instead of Maximus.

State of Wyoming cut its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 68.4% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,527 shares of the health services provider's stock after selling 7,624 shares during the quarter. State of Wyoming's holdings in Maximus were worth $241,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in MMS. Caitong International Asset Management Co. Ltd grew its position in Maximus by 17,533.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock worth $36,000 after buying an additional 526 shares in the last quarter. UMB Bank n.a. grew its position in Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after buying an additional 250 shares in the last quarter. GAMMA Investing LLC grew its position in Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after buying an additional 294 shares in the last quarter. NBC Securities Inc. grew its position in Maximus by 114,900.0% during the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after buying an additional 1,149 shares in the last quarter. Finally, Blue Trust Inc. grew its position in Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after buying an additional 303 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on MMS shares. Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to MarketBeat, Maximus has an average rating of "Strong Buy" and a consensus target price of $90.00.

View Our Latest Research Report on MMS

Maximus Trading Down 1.1%

NYSE MMS opened at $88.48 on Thursday. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.94. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The stock has a 50-day moving average of $77.50 and a 200-day moving average of $72.08. The firm has a market cap of $4.99 billion, a PE ratio of 16.29 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the previous year, the company posted $1.74 EPS. Maximus's revenue for the quarter was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, sell-side analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Sunday, August 31st. Shareholders of record on Friday, August 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's dividend payout ratio is presently 22.10%.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.